| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 676128
[patent_doc_number] => 07087627
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-08
[patent_title] => 'Combinations for the treatment of diseases involving angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 09/890989
[patent_app_country] => US
[patent_app_date] => 2000-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2581
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/087/07087627.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890989
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890989 | Combinations for the treatment of diseases involving angiogenesis | Feb 14, 2000 | Issued |
Array
(
[id] => 648677
[patent_doc_number] => 07115261
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-03
[patent_title] => 'Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies'
[patent_app_type] => utility
[patent_app_number] => 09/502732
[patent_app_country] => US
[patent_app_date] => 2000-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 13410
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115261.pdf
[firstpage_image] =>[orig_patent_app_number] => 09502732
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/502732 | Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies | Feb 10, 2000 | Issued |
Array
(
[id] => 793270
[patent_doc_number] => 06982316
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-03
[patent_title] => 'Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer'
[patent_app_type] => utility
[patent_app_number] => 09/502945
[patent_app_country] => US
[patent_app_date] => 2000-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3757
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982316.pdf
[firstpage_image] =>[orig_patent_app_number] => 09502945
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/502945 | Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer | Feb 10, 2000 | Issued |
Array
(
[id] => 938494
[patent_doc_number] => 06972323
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-06
[patent_title] => 'Anti-Fas antibodies'
[patent_app_type] => utility
[patent_app_number] => 09/499662
[patent_app_country] => US
[patent_app_date] => 2000-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 73
[patent_no_of_words] => 66847
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/972/06972323.pdf
[firstpage_image] =>[orig_patent_app_number] => 09499662
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/499662 | Anti-Fas antibodies | Feb 8, 2000 | Issued |
Array
(
[id] => 452181
[patent_doc_number] => 07247310
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-07-24
[patent_title] => 'Tumor vaccines'
[patent_app_type] => utility
[patent_app_number] => 09/890266
[patent_app_country] => US
[patent_app_date] => 2000-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 8780
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/247/07247310.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890266
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890266 | Tumor vaccines | Feb 8, 2000 | Issued |
Array
(
[id] => 1115362
[patent_doc_number] => 06800469
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-05
[patent_title] => 'Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens'
[patent_app_type] => B1
[patent_app_number] => 09/490700
[patent_app_country] => US
[patent_app_date] => 2000-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 36
[patent_no_of_words] => 22011
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800469.pdf
[firstpage_image] =>[orig_patent_app_number] => 09490700
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/490700 | Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens | Jan 23, 2000 | Issued |
| 09/488393 | Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents | Jan 19, 2000 | Abandoned |
Array
(
[id] => 1312747
[patent_doc_number] => 06613882
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest'
[patent_app_type] => B1
[patent_app_number] => 09/484471
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 6615
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613882.pdf
[firstpage_image] =>[orig_patent_app_number] => 09484471
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/484471 | Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest | Jan 17, 2000 | Issued |
Array
(
[id] => 1245529
[patent_doc_number] => 06677128
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-13
[patent_title] => 'Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum'
[patent_app_type] => B1
[patent_app_number] => 09/464840
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 6715
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677128.pdf
[firstpage_image] =>[orig_patent_app_number] => 09464840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/464840 | Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum | Dec 15, 1999 | Issued |
Array
(
[id] => 526362
[patent_doc_number] => 07183251
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-02-27
[patent_title] => 'hCG therapy for the treatment of breast cancer'
[patent_app_type] => utility
[patent_app_number] => 09/868196
[patent_app_country] => US
[patent_app_date] => 1999-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 11728
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183251.pdf
[firstpage_image] =>[orig_patent_app_number] => 09868196
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/868196 | hCG therapy for the treatment of breast cancer | Dec 14, 1999 | Issued |
Array
(
[id] => 938300
[patent_doc_number] => 06972128
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-06
[patent_title] => 'Use of human prostrate cell lines in prostate cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 09/857691
[patent_app_country] => US
[patent_app_date] => 1999-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 4840
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/972/06972128.pdf
[firstpage_image] =>[orig_patent_app_number] => 09857691
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/857691 | Use of human prostrate cell lines in prostate cancer treatment | Dec 8, 1999 | Issued |
Array
(
[id] => 1202522
[patent_doc_number] => 06720159
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-13
[patent_title] => '88KDA tumorigenic growth factor and antagonists'
[patent_app_type] => B1
[patent_app_number] => 09/456886
[patent_app_country] => US
[patent_app_date] => 1999-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 25184
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/720/06720159.pdf
[firstpage_image] =>[orig_patent_app_number] => 09456886
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/456886 | 88KDA tumorigenic growth factor and antagonists | Dec 7, 1999 | Issued |
Array
(
[id] => 1110681
[patent_doc_number] => 06806071
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-19
[patent_title] => 'Glutathione S-transferase'
[patent_app_type] => B1
[patent_app_number] => 09/441723
[patent_app_country] => US
[patent_app_date] => 1999-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19755
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/806/06806071.pdf
[firstpage_image] =>[orig_patent_app_number] => 09441723
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/441723 | Glutathione S-transferase | Nov 15, 1999 | Issued |
Array
(
[id] => 793276
[patent_doc_number] => 06982322
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-03
[patent_title] => 'Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip'
[patent_app_type] => utility
[patent_app_number] => 09/830338
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5898
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982322.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830338
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830338 | Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip | Oct 21, 1999 | Issued |
| 09/418887 | REAGENTS AND METHODS USEFUL FOR DETECTING DISEASES OF THE PROSTATE | Oct 14, 1999 | Abandoned |
Array
(
[id] => 1043747
[patent_doc_number] => 06867180
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-15
[patent_title] => 'Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth'
[patent_app_type] => utility
[patent_app_number] => 09/807148
[patent_app_country] => US
[patent_app_date] => 1999-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 19951
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867180.pdf
[firstpage_image] =>[orig_patent_app_number] => 09807148
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/807148 | Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth | Oct 4, 1999 | Issued |
Array
(
[id] => 742008
[patent_doc_number] => 07030231
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-18
[patent_title] => 'Membrane type serine protease 1 (MT-SP1) and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/410362
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 36451
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/030/07030231.pdf
[firstpage_image] =>[orig_patent_app_number] => 09410362
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/410362 | Membrane type serine protease 1 (MT-SP1) and uses thereof | Sep 29, 1999 | Issued |
Array
(
[id] => 485927
[patent_doc_number] => 07217686
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-05-15
[patent_title] => 'DNA sequence encoding oncofetal ferritin protein'
[patent_app_type] => utility
[patent_app_number] => 09/786867
[patent_app_country] => US
[patent_app_date] => 1999-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 12153
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217686.pdf
[firstpage_image] =>[orig_patent_app_number] => 09786867
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/786867 | DNA sequence encoding oncofetal ferritin protein | Sep 7, 1999 | Issued |
Array
(
[id] => 479257
[patent_doc_number] => 07223850
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-05-29
[patent_title] => 'Apoptosis proteins'
[patent_app_type] => utility
[patent_app_number] => 09/762491
[patent_app_country] => US
[patent_app_date] => 1999-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 22640
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223850.pdf
[firstpage_image] =>[orig_patent_app_number] => 09762491
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/762491 | Apoptosis proteins | Aug 5, 1999 | Issued |
Array
(
[id] => 680601
[patent_doc_number] => 07084249
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-01
[patent_title] => 'Tumor associated antigen peptides and use of same as anti-tumor vaccines'
[patent_app_type] => utility
[patent_app_number] => 09/744804
[patent_app_country] => US
[patent_app_date] => 1999-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 30
[patent_no_of_words] => 20769
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/084/07084249.pdf
[firstpage_image] =>[orig_patent_app_number] => 09744804
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/744804 | Tumor associated antigen peptides and use of same as anti-tumor vaccines | Jul 28, 1999 | Issued |